Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04053400 · ClinicalTrials.gov registry record
Evaluating Ketamine and Psychological Sequelae
A clinical trial, sponsored by Defense and Veterans Center for Integrative Pain Management.
- Completed
- Registry status
- 159
- Enrollment target
NCT04053400 is a clinical trial that has completed, run by Defense and Veterans Center for Integrative Pain Management. The registered enrollment target is 159 participants.
The verdict
NCT04053400 has completed, sponsored by Defense and Veterans Center for Integrative Pain Management.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the relationship between the use of intravenous infusion of sub-anesthetic dosages of ketamine given for pain to combat casualties and emerging symptoms of Post-Traumatic Stress Disorder (PTSD), depression, anxiety, sleep disruption, and risk of alcohol abuse as identified with behavioral health screening tools. Although ketamine has gained popularity as an analgesic agent, literature related to its psychological impact is sparse.
Interventions
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-09-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04053400
The ClinicalTrials.gov registry entry for NCT04053400 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Defense and Veterans Center for Integrative Pain Management, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine is the first listed.
NCT04053400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04053400 about?
NCT04053400 is a clinical study titled "Evaluating Ketamine and Psychological Sequelae". The purpose of this study is to examine the relationship between the use of intravenous infusion of sub-anesthetic dosages of ketamine given for pain to combat casualties and emerging symptoms of Post-Traumatic Stress Disorder (PTSD), depression, anxiety, sleep disruption, and risk of alcohol abuse ...
What is the current status of trial NCT04053400?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2014-12. Estimated completion is 2017-09-13.
What interventions are being tested in trial NCT04053400?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT04053400?
This trial is sponsored by Defense and Veterans Center for Integrative Pain Management, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.